{"id":"asthma-therapies","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Upper respiratory tract infections"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nasopharyngitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Genentech's asthma portfolio includes biologics such as omalizumab (anti-IgE monoclonal antibody), reslizumab (anti-IL-5 monoclonal antibody), and dupilumab (anti-IL-4 receptor alpha monoclonal antibody), each targeting specific inflammatory pathways involved in asthma pathogenesis. These agents reduce eosinophil recruitment, IgE-mediated mast cell activation, and type 2 inflammatory responses to improve asthma control and reduce exacerbations.","oneSentence":"Asthma therapies from Genentech include multiple marketed drugs that work through different mechanisms to reduce airway inflammation and improve lung function in asthma patients.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:27:54.903Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe allergic asthma"},{"name":"Moderate to severe eosinophilic asthma"},{"name":"Moderate to severe atopic dermatitis with asthma"}]},"trialDetails":[{"nctId":"NCT04886999","phase":"PHASE3","title":"Study in Adult Patients With Moderate to Severe Asthma","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2022-02-24","conditions":"Asthma","enrollment":78},{"nctId":"NCT06724848","phase":"","title":"A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-06-05","conditions":"COPD","enrollment":850},{"nctId":"NCT06379607","phase":"NA","title":"High Flow Nasal Cannula Rates in Pediatric Asthma","status":"WITHDRAWN","sponsor":"University of Rochester","startDate":"2025-01-15","conditions":"Pediatric Asthma","enrollment":""},{"nctId":"NCT06676319","phase":"PHASE2","title":"Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-11-07","conditions":"Asthma","enrollment":1147},{"nctId":"NCT07489911","phase":"","title":"Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH)","status":"RECRUITING","sponsor":"Chiesi Slovenija, d.o.o.","startDate":"2024-11-04","conditions":"Asthma, Asthma Patients, Asthma Bronchiale","enrollment":200},{"nctId":"NCT07228026","phase":"","title":"Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects","status":"RECRUITING","sponsor":"Biometry Inc","startDate":"2025-09-17","conditions":"Asthma","enrollment":160},{"nctId":"NCT04157361","phase":"","title":"Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.","status":"RECRUITING","sponsor":"The Institute of Molecular and Translational Medicine, Czech Republic","startDate":"2015-05-01","conditions":"Bronchial Asthma, Pulmonary Cystic Fibrosis","enrollment":450},{"nctId":"NCT05935332","phase":"PHASE2","title":"Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma","status":"TERMINATED","sponsor":"RAPT Therapeutics, Inc.","startDate":"2023-07-05","conditions":"Asthma","enrollment":38},{"nctId":"NCT07488598","phase":"NA","title":"Efficacy of Behavioral Therapy for Chronic Refractory Cough","status":"RECRUITING","sponsor":"Assiut University","startDate":"2026-03-10","conditions":"Chronic Cough","enrollment":30},{"nctId":"NCT05744869","phase":"NA","title":"SBAT for Health Equity","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-08-01","conditions":"Asthma in Children","enrollment":300},{"nctId":"NCT06651385","phase":"NA","title":"Pilot of Exercise and Asthma Control","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2024-10-01","conditions":"Asthma, Obesity","enrollment":20},{"nctId":"NCT07219173","phase":"PHASE2","title":"A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-10-22","conditions":"Asthma","enrollment":531},{"nctId":"NCT07044388","phase":"NA","title":"Coping With Asthma Throughout Life Management Program","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-06-15","conditions":"Asthma, Stress","enrollment":50},{"nctId":"NCT07486401","phase":"NA","title":"Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)","status":"RECRUITING","sponsor":"National Healthcare Group Polyclinics","startDate":"2025-12-03","conditions":"Asthma Exacerbations, Biomarkers / Blood, Eosinophil Blood Count","enrollment":240},{"nctId":"NCT07412990","phase":"","title":"GRASS (Grass MATA MPL Real-world Assessment Study)","status":"RECRUITING","sponsor":"Allergy Therapeutics","startDate":"2026-03-11","conditions":"Grass Pollen Allergy","enrollment":1000},{"nctId":"NCT06786767","phase":"","title":"Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting","status":"COMPLETED","sponsor":"Chiesi Bulgaria","startDate":"2025-02-01","conditions":"Asthma, Asthma Patients, Asthma Bronchiale","enrollment":281},{"nctId":"NCT04706988","phase":"","title":"Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2021-06-22","conditions":"Asthma","enrollment":140},{"nctId":"NCT06750289","phase":"PHASE3","title":"Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-28","conditions":"Eosinophilic Asthma","enrollment":400},{"nctId":"NCT03890666","phase":"PHASE4","title":"A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2020-10-26","conditions":"Asthma","enrollment":333},{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT07363642","phase":"PHASE3","title":"Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-28","conditions":"Severe Asthma","enrollment":400},{"nctId":"NCT07480369","phase":"NA","title":"Vegan Diet and Immune-Inflammatory Outcomes in Asthma and Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2026-03","conditions":"Asthma, Dietary Intervention, Vegan Diet","enrollment":280},{"nctId":"NCT05002621","phase":"","title":"Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2021-02-16","conditions":"Eosinophilic Asthma","enrollment":20},{"nctId":"NCT01233297","phase":"PHASE2","title":"Antibiotic Treatment of Recurrent Episodes of Asthma in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2010-11","conditions":"Childhood Asthma With Acute Exacerbation","enrollment":70},{"nctId":"NCT04639791","phase":"","title":"To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2021-03-01","conditions":"Asthma","enrollment":500},{"nctId":"NCT05991115","phase":"NA","title":"Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care","status":"RECRUITING","sponsor":"Kavita Parikh","startDate":"2024-01-22","conditions":"Asthma, Asthma in Children","enrollment":340},{"nctId":"NCT07472738","phase":"","title":"Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases","status":"RECRUITING","sponsor":"Beijing Chao Yang Hospital","startDate":"2025-05-07","conditions":"Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Chronic Airway Diseases","enrollment":950},{"nctId":"NCT07472283","phase":"","title":"Design, Development and Evaluation of a Digital Health Assistant for Paediatric Asthma","status":"NOT_YET_RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2026-04","conditions":"Paediatric Asthma","enrollment":42},{"nctId":"NCT05851443","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2023-07-11","conditions":"Moderate to Severe Asthma","enrollment":240},{"nctId":"NCT07426458","phase":"PHASE4","title":"Ventilation and Perfusion in Asthmatics","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-04","conditions":"Asthma","enrollment":40},{"nctId":"NCT07141277","phase":"","title":"GRANITE: Airsupra Effectiveness in the Real World","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-07-09","conditions":"Asthma","enrollment":4000},{"nctId":"NCT07037511","phase":"NA","title":"Effects of Salbutamol in Athletes and Implications for Screening and Sports","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-10-30","conditions":"Asthma, Healthy, Effect of Drug","enrollment":64},{"nctId":"NCT06113640","phase":"PHASE2, PHASE3","title":"Montelukast in Parkinson Disease","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2023-11-05","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT06705764","phase":"PHASE4","title":"Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)","status":"NOT_YET_RECRUITING","sponsor":"University of Alberta","startDate":"2026-04-01","conditions":"Severe Asthma","enrollment":100},{"nctId":"NCT07433569","phase":"PHASE1","title":"A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-03-05","conditions":"Asthma","enrollment":12},{"nctId":"NCT06473779","phase":"PHASE3","title":"Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-30","conditions":"Severe Asthma","enrollment":326},{"nctId":"NCT06596512","phase":"NA","title":"Improving the Quality of Care for Asthma Patients at Risk of Exacerbations","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-07","conditions":"Asthma, Asthma Chronic, Asthma Severe Persistent With Exacerbation","enrollment":4100},{"nctId":"NCT06724575","phase":"","title":"EVOLVE Study: The Real-life Clinical Practice With Tezepelumab in Greece","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-12-17","conditions":"Asthma","enrollment":155},{"nctId":"NCT06419413","phase":"","title":"A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-01-08","conditions":"Asthma","enrollment":355},{"nctId":"NCT07453771","phase":"NA","title":"Safety and Efficacy of Small Extracellular Vesicles Nebulizer in Patients With Allergic Rhinitis Complicated With Asthma","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2026-03-05","conditions":"Allergic Rhinitis, Asthma","enrollment":18},{"nctId":"NCT05254314","phase":"PHASE2","title":"Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2022-10-11","conditions":"Asthma","enrollment":100},{"nctId":"NCT06307665","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-05-20","conditions":"Asthma","enrollment":440},{"nctId":"NCT07301255","phase":"PHASE2","title":"ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2026-01-09","conditions":"Asthma","enrollment":50},{"nctId":"NCT06951867","phase":"","title":"Tezspire Cardiac Events PASS","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-09-15","conditions":"Cardiovascular Events, MACE","enrollment":16640},{"nctId":"NCT07445334","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes","status":"NOT_YET_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2026-03-01","conditions":"Premature Ventricular Complexes, Premature Ventricular Contraction (PVC), Premature Ventricular Beats","enrollment":40},{"nctId":"NCT07444567","phase":"PHASE3","title":"Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-03-27","conditions":"Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES)","enrollment":230},{"nctId":"NCT06948396","phase":"","title":"Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-25","conditions":"Asthma","enrollment":300},{"nctId":"NCT01931696","phase":"NA","title":"Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma","status":"COMPLETED","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2013-08","conditions":"Asthma","enrollment":200},{"nctId":"NCT06563102","phase":"PHASE4","title":"Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-09-11","conditions":"Mild Asthma","enrollment":101},{"nctId":"NCT07436221","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Asthma","status":"NOT_YET_RECRUITING","sponsor":"Akeso","startDate":"2026-02-28","conditions":"Asthma","enrollment":160},{"nctId":"NCT06389058","phase":"","title":"Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System","status":"ACTIVE_NOT_RECRUITING","sponsor":"San Diego State University","startDate":"2023-05-01","conditions":"Severe Asthma","enrollment":31795},{"nctId":"NCT07436104","phase":"PHASE4","title":"Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.","status":"COMPLETED","sponsor":"MAHAN Trust","startDate":"2004-01-01","conditions":"Hypertension (HTN), Diarrhea, Pneumonia","enrollment":72564},{"nctId":"NCT06261957","phase":"PHASE3","title":"A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-05-31","conditions":"Asthma","enrollment":477},{"nctId":"NCT07359846","phase":"PHASE3","title":"A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)","status":"RECRUITING","sponsor":"Generate Biomedicines","startDate":"2026-01-20","conditions":"Severe Asthma","enrollment":786},{"nctId":"NCT04287621","phase":"","title":"Registry of Asthma Patients Initiating DUPIXENT®","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2020-03-02","conditions":"Asthma","enrollment":718},{"nctId":"NCT06457009","phase":"NA","title":"Impact of Multi-Component Intervention on Suspected Asthma Population","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking Union Medical College","startDate":"2024-06-17","conditions":"Multimorbidity, Chronic Asthma, Population Medicine","enrollment":7400},{"nctId":"NCT06458205","phase":"NA","title":"Impact of Multi-Component Interventions on High-Risk COPD Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking Union Medical College","startDate":"2024-06-17","conditions":"Multimorbidity, Tobacco Use Cessation, Smoking Reduction","enrollment":7400},{"nctId":"NCT06623981","phase":"NA","title":"The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic","status":"RECRUITING","sponsor":"Children's National Research Institute","startDate":"2024-10-15","conditions":"Asthma in Children, Depression","enrollment":60},{"nctId":"NCT04901455","phase":"EARLY_PHASE1","title":"Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-10-03","conditions":"COPD","enrollment":24},{"nctId":"NCT07427576","phase":"","title":"Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte","status":"COMPLETED","sponsor":"Inmunotek S.L.","startDate":"2025-03-31","conditions":"Mite Allergy, Dermatophagoides Farinae Allergy, Dermatophagoides Pteronyssinus Allergy","enrollment":140},{"nctId":"NCT03694158","phase":"PHASE4","title":"Investigating Dupilumab's Effect in Asthma by Genotype","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2021-09-08","conditions":"Asthma","enrollment":150},{"nctId":"NCT05222529","phase":"PHASE2","title":"Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-29","conditions":"Asthma","enrollment":42},{"nctId":"NCT05562466","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-05-11","conditions":"Asthma","enrollment":200},{"nctId":"NCT05168995","phase":"","title":"Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control","status":"COMPLETED","sponsor":"Chiesi Italia","startDate":"2022-04-12","conditions":"Asthma","enrollment":620},{"nctId":"NCT04157335","phase":"PHASE3","title":"Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2019-11-25","conditions":"Nasal Polyposis, Eosinophilic Chronic Rhinosinusitis","enrollment":295},{"nctId":"NCT06977581","phase":"PHASE2","title":"A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-05-20","conditions":"Asthma","enrollment":252},{"nctId":"NCT07059091","phase":"PHASE2","title":"Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Allergies","enrollment":334},{"nctId":"NCT06837584","phase":"","title":"Control and Treatment of Outpatient Children With Asthma","status":"NOT_YET_RECRUITING","sponsor":"Beijing Children's Hospital","startDate":"2026-04-01","conditions":"Asthma","enrollment":42000},{"nctId":"NCT07276724","phase":"PHASE3","title":"A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)","status":"RECRUITING","sponsor":"Generate Biomedicines","startDate":"2025-12-03","conditions":"Severe Asthma","enrollment":786},{"nctId":"NCT07412769","phase":"","title":"ASMact: Study on Management of Bronchial Asthma","status":"RECRUITING","sponsor":"Meyer Children's Hospital IRCCS","startDate":"2025-11-05","conditions":"Asthma Acute, Asthma Childhood, Asthma in Children","enrollment":500},{"nctId":"NCT06940141","phase":"PHASE2","title":"Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)","status":"RECRUITING","sponsor":"Connect Biopharm LLC","startDate":"2025-08-08","conditions":"Asthma Acute","enrollment":160},{"nctId":"NCT06502366","phase":"PHASE3","title":"A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-07-22","conditions":"Asthma","enrollment":422},{"nctId":"NCT07411040","phase":"NA","title":"Effects of Body Awareness Therapy on Physical and Psychosocial Outcomes in Adults With Asthma","status":"NOT_YET_RECRUITING","sponsor":"Recep Tayyip Erdogan University","startDate":"2026-02-01","conditions":"Asthma","enrollment":67},{"nctId":"NCT07282886","phase":"PHASE2","title":"VENTURI (VENTilation Using Respiratory Imaging)","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-03-15","conditions":"Asthma","enrollment":20},{"nctId":"NCT04550962","phase":"","title":"Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2020-11-02","conditions":"Asthma","enrollment":376},{"nctId":"NCT05013788","phase":"NA","title":"Using Social Media to Decrease Healthcare Utilization for Pediatric Asthma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-10-01","conditions":"Asthma in Children","enrollment":200},{"nctId":"NCT06706336","phase":"NA","title":"Radon Asthma Intervention Trial","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-06-01","conditions":"Asthma","enrollment":180},{"nctId":"NCT00585039","phase":"PHASE4","title":"Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)","status":"COMPLETED","sponsor":"Phoenix Children's Hospital","startDate":"2005-09","conditions":"Asthma","enrollment":101},{"nctId":"NCT03032744","phase":"NA","title":"Aligning With Schools To Help Manage Asthma (Project ASTHMA)","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2017-01-17","conditions":"Asthma","enrollment":29},{"nctId":"NCT07396987","phase":"NA","title":"Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation","status":"NOT_YET_RECRUITING","sponsor":"Juan Carlos Cardet","startDate":"2026-02","conditions":"Asthma Attack, Asthma Control, Asthma Exacerbations","enrollment":40},{"nctId":"NCT07397676","phase":"NA","title":"Quality of Life - Effects of a Physical Therapy Intervention to for Children and Adolescents With Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karolinska University Hospital","startDate":"2024-08-30","conditions":"Paediatric Asthma, Paediatric Dysfunctional Breathing","enrollment":40},{"nctId":"NCT05850494","phase":"PHASE3","title":"Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-05-02","conditions":"Asthma","enrollment":52},{"nctId":"NCT07390669","phase":"NA","title":"OptimAIR: Towards Right Care in Asthma Through Point-of-care Phenotyping, Guideline-based Assessment and Management Optimalisation Using the AsthmaOptimiser in Primary Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"General Practitioners Research Institute","startDate":"2025-05-01","conditions":"Asthma Control","enrollment":746},{"nctId":"NCT06566885","phase":"","title":"Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-09-10","conditions":"Severe Asthma","enrollment":125},{"nctId":"NCT07223294","phase":"PHASE3","title":"Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma","status":"NOT_YET_RECRUITING","sponsor":"Sandoz","startDate":"2026-04","conditions":"Respiratory","enrollment":1430},{"nctId":"NCT07372521","phase":"","title":"Measuring Small-Airways Disease Improvement After Step-up to Extrafine TRIple or High-dose ICS/LABA in Patients Uncontrolled on Medium Dose ICS/LABA eXploring T2 Inflammation","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Ioannina","startDate":"2026-01-19","conditions":"Asthma","enrollment":130},{"nctId":"NCT05186025","phase":"","title":"Tyrosine Allergoid Paediatric and Adult Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Allergy Therapeutics","startDate":"2020-11-06","conditions":"Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, Allergic Asthma","enrollment":320},{"nctId":"NCT06680947","phase":"PHASE2","title":"A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.","startDate":"2024-12-20","conditions":"Asthma","enrollment":225},{"nctId":"NCT06796387","phase":"NA","title":"SMART-School-based Asthma Therapy","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-12","conditions":"Asthma in Children","enrollment":330},{"nctId":"NCT01478152","phase":"NA","title":"Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2009-08","conditions":"Asthma","enrollment":18},{"nctId":"NCT07372573","phase":"NA","title":"Pressurized Meter Dose Inhaler V/S Dry Powder Inhaler","status":"NOT_YET_RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2026-02-01","conditions":"Asthma (Diagnosis)","enrollment":210},{"nctId":"NCT07280364","phase":"","title":"Metabolomics in the Diagnosis and Treatment of Asthma in Children","status":"RECRUITING","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2024-03-13","conditions":"Asthma","enrollment":100},{"nctId":"NCT05091385","phase":"","title":"Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2022-01-01","conditions":"Asthma; Eosinophilic","enrollment":106},{"nctId":"NCT05704101","phase":"","title":"NHFT Effects on Symptatheic Drive of Asthma Patients","status":"COMPLETED","sponsor":"RWTH Aachen University","startDate":"2023-07-01","conditions":"Asthma","enrollment":30},{"nctId":"NCT05555290","phase":"PHASE3","title":"PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-09-28","conditions":"Asthma","enrollment":190},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT07351916","phase":"","title":"Remission in Adults With Mild-to-moderate Asthma in Thailand","status":"NOT_YET_RECRUITING","sponsor":"Thammasat University","startDate":"2026-02-01","conditions":"Asthma, Mild-to-moderate Asthma, Asthma Control Level","enrollment":289},{"nctId":"NCT07364643","phase":"NA","title":"Effectiveness of an Educational Intervention on Asthmatic Children in Inhaled Technique and Adherence.","status":"NOT_YET_RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2026-01","conditions":"Asthma Childhood","enrollment":428},{"nctId":"NCT00584636","phase":"PHASE4","title":"Pulmicort Respules on Relapse Rates After Treatment in the ED","status":"WITHDRAWN","sponsor":"Phoenix Children's Hospital","startDate":"2007-10","conditions":"Asthma","enrollment":""},{"nctId":"NCT07362667","phase":"","title":"A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2026-01-10","conditions":"ABPA, Allergic Bronchopulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":347,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Asthma therapies","genericName":"Asthma therapies","companyName":"Genentech, Inc.","companyId":"genentech-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Asthma therapies from Genentech include multiple marketed drugs that work through different mechanisms to reduce airway inflammation and improve lung function in asthma patients. Used for Moderate to severe allergic asthma, Moderate to severe eosinophilic asthma, Moderate to severe atopic dermatitis with asthma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}